Cargando…
Circulating Biomarkers of Colorectal Cancer (CRC)—Their Utility in Diagnosis and Prognosis
The global burden of colorectal cancer (CRC) is expected to increase, with 2.2 million new cases and 1.1 million annual deaths by 2030. Therefore, the establishment of novel biomarkers useful in the early diagnosis of CRC is of utmost importance. A number of publications have documented the signific...
Autores principales: | Łukaszewicz-Zając, Marta, Mroczko, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199026/ https://www.ncbi.nlm.nih.gov/pubmed/34071492 http://dx.doi.org/10.3390/jcm10112391 |
Ejemplares similares
-
The Comprehensive Analysis of Specific Proteins as Novel Biomarkers Involved in the Diagnosis and Progression of Gastric Cancer
por: Pawluczuk, Elżbieta, et al.
Publicado: (2023) -
Granzymes—Their Role in Colorectal Cancer
por: Pączek, Sara, et al.
Publicado: (2022) -
Chemokines—What Is Their Role in Colorectal Cancer?
por: Pączek, Sara, et al.
Publicado: (2020) -
CXCL-8 in Preoperative Colorectal Cancer Patients: Significance for Diagnosis and Cancer Progression
por: Pączek, Sara, et al.
Publicado: (2020) -
A Disintegrin and Metalloproteinase (ADAM) Family—Novel Biomarkers of Selected Gastrointestinal (GI) Malignancies?
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2022)